Uncomplicated plasmodium falciparum malaria
Clinical trials for Uncomplicated plasmodium falciparum malaria explained in plain language.
Never miss a new study
Get alerted when new Uncomplicated plasmodium falciparum malaria trials appear
Sign up with your email to follow new studies for Uncomplicated plasmodium falciparum malaria, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Drug malaria punch targets faster cure in kids
Cure Recruiting nowResearchers are testing whether a combination of cipargamin and KLU156 (ganaplacide plus lumefantrine) can cure uncomplicated Plasmodium falciparum malaria in children aged 2 to under 12. The trial compares this oral regimen with standard Coartem treatment. The main goal is to se…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
New triple drug combo could beat malaria resistance
Cure Recruiting nowThis study tests a new triple-drug combination (artemether-lumefantrine-amodiaquine) against standard two-drug treatments for uncomplicated malaria. About 1680 people with malaria will receive one of the treatments and be monitored for 42 days. The goal is to see if the triple th…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase 3 • Sponsor: University of Oxford • Aim: Cure
Last updated Jun 27, 2026 07:58 UTC